title: Presumed recurrence of intracranial Rosai-Dorfman disease as a cervical spine tumor.
abstract: Sinus histiocytosis with massive lymphadenopathy, Rosai-Dorfman disease (RDD) rarely involves the central nervous system. Previously reported lesions in the spine were primary occurrences. We report a patient who developed presumed secondary symptomatic involvement of the spine five years following therapy for a primary intracranial RDD.
authors: Department of Radiotherapy and Radiology, Tabriz Medical University, Tabriz, Iran.
authors: F
authors: F
authors: Seyednejad
authors: R S
authors: RS
authors: Tubbs
authors: M M
authors: MM
authors: Shoja
authors: M H
authors: MH
authors: Daghigi
authors: W J
authors: WJ
authors: Oakes
mesh_terms: D000293:Adolescent; D000328:Adult; D002574:Cervical Vertebrae / Q000473:pathology* / Q000503:physiopathology; D003388:Cranial Fossa, Posterior / Q000473:pathology*; D005260:Female; D015618:Histiocytosis, Sinus / Q000150:complications / Q000473:pathology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008297:Male; D011239:Prednisolone / Q000627:therapeutic use; D011878:Radiotherapy; D013120:Spinal Cord Neoplasms / Q000473:pathology* / Q000503:physiopathology; D013122:Spinal Diseases / Q000209:etiology / Q000473:pathology* / Q000503:physiopathology; D013346:Subarachnoid Space / Q000473:pathology / Q000503:physiopathology; D013355:Subdural Space / Q000473:pathology / Q000503:physiopathology; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D011239:Prednisolone